New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
06:48 EDTPTCTPTC Therapeutics files automatic mixed securities shelf
News For PTCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2014
18:36 EDTPTCTPTC Therapeutics 3M share Spot Secondary priced at $36.25
Subscribe for More Information
October 8, 2014
16:25 EDTPTCTPTC Therapeutics files to sell 3M shares of common stock
Credit Suisse and Citigroup are acting as joint lead book-running managers for the offering. Cowen and Company, Deutsche Bank Securities and RBC Capital Markets are acting as book-running managers.
October 7, 2014
07:46 EDTPTCTPTC Therapeutics weakness a buying opportunity, says Oppenheimer
Oppenheimer believes that the Street is underestimating the opportunity for PTC Therapeutics' (PTCT) Translarna in the most severe patients with Cystic fibrosis. The firm thinks the drug is not competitive with, and can potentially be complemented by, therapies from Vertex (VRTX). Oppenheimer views the weakness in PTC as a buying opportunity and keeps its Outperform rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use